Lilavati Hospital and Research Centre is preparing for a large-scale expansion that could add about 5,000 beds to its network in India and international markets within the next two years.
The Mumbai-based healthcare institution is planning new hospitals in Ahmedabad, Indore and Delhi. Ahmedabad is expected to be the first of these projects to become operational in India.
At the same time, Lilavati is taking its healthcare services beyond the country. Kazakhstan and Oman are among the international markets identified for expansion, with Kazakhstan set to become the hospital’s first overseas destination.
Kazakhstan to Start as Specialist Outpatient Centre
Lilavati plans to begin operations in Kazakhstan with a super-speciality outpatient centre in early September 2026.
The facility will initially operate without inpatient beds. Its services will focus on specialist consultations, second opinions and guidance on treatment options.
Patients will have access to expertise in several medical areas, including cancer care, liver and hepatobiliary treatment, kidney care and transplantation, cardiology, neurology, neurosurgery, IVF, reproductive medicine, gastroenterology, orthopaedics, urology, endocrinology and diabetes. Paediatric and pulmonary care will also be part of the services.
Treatment to Be Divided Between Kazakhstan and Mumbai
Lilavati’s model in Kazakhstan will depend on the complexity of each case.
According to Dr Ravindra Karanjekar, CEO of Lilavati Hospital and Research Centre, patients who can be treated within Kazakhstan will receive care through partnerships with local hospitals. Lilavati doctors will support such cases through consultations and clinical guidance.
For patients requiring specialised surgery or advanced treatment unavailable locally, the hospital will create a referral route to its Mumbai facility.
This approach will allow Lilavati to provide international patients with access to its specialists while also working with healthcare providers in the local market.
Kazakhstan to Lead Central Asia Strategy
The hospital views its Kazakhstan entry as more than an individual overseas project. It is intended to provide a base for expanding its healthcare presence across Central Asia and the wider Commonwealth of Independent States (CIS) region.
The strategy also reflects Lilavati’s broader ambition to take its clinical expertise to patients outside India and build partnerships in international healthcare markets.
Explaining the role of Kazakhstan in this strategy, Dr Karanjekar said: “Complex cases would have a structured pathway to access advanced care at Lilavati Hospital Mumbai, while Kazakhstan would serve as the first step towards a wider Central Asian presence,” he said.
Expansion Across India and Overseas
The planned growth will give Lilavati a wider footprint at a time when healthcare providers are increasingly looking beyond their traditional markets.
With projects planned in three major Indian cities and international opportunities being pursued in markets such as Kazakhstan and Oman, the hospital is positioning its next phase of growth around both domestic capacity and overseas reach.
Lilavati’s planned 5,000-bed expansion marks a significant growth phase for the Mumbai healthcare institution. The Kazakhstan OPD will provide its first international foothold, while the planned Indian facilities and future overseas projects could help build a broader healthcare network over the coming years.